MNCHIP logo — company profile

MNCHIP

Founded 2010 China China 16 employees Series B Total: $33.00M Biotechnology, Health Care +1

General Information

Company Name MNCHIP
Founded Year 2010
Location China China +1
Employees 16
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series B
Social

Get notified when MNCHIP moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MNCHIP

MNCHIP is a provider of microfluidic devices for in-vitro diagnostics (IVD). Founded in 2010 in China, the company is dedicated to simplifying the complex process of biochemical testing and reducing medical expenses through the application of advanced microfluidic technology. MNCHIP's commitment to improving human and animal health is evidenced by their two series of medical and veterinary chemistry analyzers—Celercare® and Pointcare®. These products have received certifications including CFDA, CE, and ISO13485, meeting the registration requirements of various countries.

The company secured a CNY20.00M Series B investment on 28 July 2015, with Legend Capital as the investor. MNCHIP's presence in the Biotechnology, Health Care, and Medical Devices industries showcases its potential in the healthcare sector and its alignment with the current market trends.

Taxonomy: microfluidic devices, in-vitro diagnostics, veterinary technology, biochemical testing, medical institutions, CFDA certification, CE certification, ISO13485 certification, biomedical devices, diagnostic equipment, healthcare certification, biochemical analysis

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 1
Investor
28 Jul 2015
Series A •••••• 1
Investor
06 Aug 2014
Angel Round •••••• 2
Investor Investor
28 Feb 2011

MNCHIP Alternatives & Competitors

MNCHIP vs

The DJOR device has the capacity to MONITOR / ANALYZE / TRACK / PREDICT health markers utilizing ora...

Seed
2 employees
AI, Analytics
MNCHIP vs

Special IV Sets Customizing Expert Oncology set, Pump Set, Extension Set, Veterinary Set, Angiograph...

6 employees
Design, Manufacturing
MNCHIP vs
Scarlet
Scarlet United Kingdom

Europe’s only Notified Body specialised in software and AI

Seed
52 employees

FAQ About MNCHIP

Tianjin MNCHIP Technologies Co., Ltd is a provider of microfluidic devices in in-vitro diagnostics (IVD). MNCHIP is committed to reducing the burden of medical expenses, simplifying the complex process of biochemical testing and applying the advanced mircofluidic technology to improve human and anim...
MNCHIP was founded in 2010.
MNCHIP is headquartered in China.
MNCHIP operates in the following industries: Biotechnology, Health Care, Medical Devices.
MNCHIP has approximately 16 employees.
MNCHIP has completed 3 funding rounds, raising a total of $33.00M. The latest funding stage is Series B.
Top alternatives and competitors to MNCHIP include Inguardia Health Inc., BQ Plus Medical Co Ltd, Scarlet, incuMeD, GA2 Medical Sdn Bhd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MNCHIP and Inguardia Health Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MNCHIP and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy